Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ArkemaARKAF 71 EV-to-EBIT is 50.66 as of Aug. 05, 2026, which is 352% above its 10-year median of 11.21. GuruFocus rates ARKAF with a GF Score™ of 71/100 and a GF Value™ of $80.00 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 1,242 Chemicals companies, Arkema ranks worse than 83.9% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Arkema's Enterprise Value is $8,785 Mil.
Arkema's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $173 Mil. Therefore, Arkema's EV-to-EBIT for today is 50.66.
The historical rank and industry rank for Arkema's EV-to-EBIT or its related term are showing as below:
ARKAF'
s EV-to-EBIT Range Over the Past 10 Years
Min: 4.16 Med: 11.21 Max: 67.89
Current: 50.47
During the past 13 years, the highest EV-to-EBIT of Arkema was 67.89. The lowest was 4.16. And the median was 11.21.
ARKAF's EV-to-EBIT is ranked worse than 83.9% of 1242
companies
in the Chemicals industry
Industry Median: 17.235
vs ARKAF: 50.47
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Arkema's Enterprise Value for the quarter that ended in Jun. 2026 was $8,628 Mil.
Arkema's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $173 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arkema EV-to-EBIT Related Terms
Arkema EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Arkema's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Arkema's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arkema EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Arkema's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Arkema's EV-to-EBIT falls into.
Arkema's current Enterprise Value is $8,785 Mil.
Arkema's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $173 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arkema (ARKAF) has a EV-to-EBIT of 50.66 as of Aug. 05, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Arkema and its competitors. This is 352% above median its historical median of 11.21. Over the past decade, Arkema's EV-to-EBIT has ranged from 4.16 to 67.89. According to the industry distribution chart, Arkema ranks #1042 out of 1242 companies in the Chemicals industry, placing it in the top 83.9%.
Is Arkema's EV-to-EBIT too high?
Arkema's current EV-to-EBIT of 50.66 is 352% above median its 10-year median of 11.21. Over the past 10 years, this metric has ranged from a low of 4.16 to a high of 67.89. The Chemicals industry median EV-to-EBIT is 17.24. Arkema's value of 50.66 is 193.9% above this industry median. Based on the distribution chart, Arkema ranks #1042 out of 1242 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Arkema has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Arkema's EV-to-EBIT compare to LIN and SHW?
According to the Chemicals industry distribution chart, Arkema ranks #1042 out of 1242 companies for EV-to-EBIT. This places Arkema in the lower half of its industry. The industry median EV-to-EBIT is 17.24. Arkema's value of 50.66 is 193.9% above this benchmark. Historically, Arkema's own EV-to-EBIT has ranged from 4.16 to 67.89 over the past decade. While the company's 10-year median is 11.21 vs. the industry median of 17.24, Arkema has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 17.24, based on 1,242 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arkema's current EV-to-EBIT of 50.66 is 193.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Arkema and its competitors. For the Chemicals industry, the median EV-to-EBIT is 17.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arkema's current EV-to-EBIT is 50.66, which is 352% above median its own 10-year median of 11.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arkema stock overvalued right now?
Based on GuruFocus' analysis, Arkema (ARKAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $80.00, compared to a current price of $68.44 — trading 14.5% below its estimated fair value. The current EV-to-EBIT is 50.66, which is 352% above median its 10-year median of 11.21 and 193.9% above the Chemicals industry median of 17.24. Arkema's overall GF Score™ is 71/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Arkema (ARKAF), the current EV-to-EBIT is 50.66 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arkema (ARKAF) Overvalued in 2026?
Based on GuruFocus' analysis, Arkema stock appears to be undervalued.
The current stock price of $68.44 is trading 14.5% below its estimated GF Value™ of $80.00.
GuruFocus considers Arkema to be Modestly Undervalued.
Key valuation signals for ARKAF:
EV-to-EBIT: 50.66 (352% above median its 10-year median of 11.21)
GF Value™: $80.00 vs. price of $68.44 (14.5% below fair value)
Industry Position: 193.9% above the Chemicals median (#1042 of 1242)
No single metric tells the full story. See the ARKAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arkema SA operates in the specialty materials industry, offering adhesives, acrylics, technical fluids, chemicals, additives, and other materials that are used in various industries globally. Along with its subsidiaries, it operates in the following segments: Adhesive Solutions, Advanced Materials, Intermediates, and Coating Solutions. Maximum revenue is generated from the Advanced Materials segment, which offers high-performance polymers, like specialty polyamides, PVDF, polyimides, fluorospecialties, and PEKK; and performance additives, covering interface agents, organic peroxides, thiochemicals, and hydrogen peroxide. Geographically, the Group generates maximum revenue from North America, followed by Europe, Asia, and the Rest of the world.
71GF Score
Get the complete analysis for ARKAF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ARKAF has been successfully added to your 
